Projected Earnings Date: 2025-10-31    (Delayed quote data   2025-09-12)
Last
 21.88
Change
 ⇓ -0.37   (-1.66%)
Volume
  178,433
Open
 22.23
High
 22.28
Low
 21.73
8EMA (Daily)
 21.99
40EMA (Daily)
 20.99
50EMA (Daily)
 20.78
STO (Daily)
 62.683
MACD Hist (Daily)
 -0.119
8EMA (Weekly)
 21.138
40EMA (Weekly)
 19.97
50EMA (Weekly)
 20.19
STO (Weekly)
 89.756
MACD Hist (Weekly)
 0.612
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; Canada; and Other Countries.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com